Showing results (101-110 of 149) with videos related to
Sort By:
Pageof 15
The Journal of Antimicrobial Chemotherapy|January 1, 1993
Efficacy and tolerance of an amphotericin B lipid (Intralipid) emulsion in the treatment of candidaemia in neutropenic patientsD Caillot, O Casasnovas, E Solary, et al.The Journal of Hospital Infection|February 13, 2017
Association between Pseudomonas aeruginosa positive water samples and healthcare-associated cases: nine-year study at one university hospitalA Lefebvre, X Bertrand, C Quantin, et al.Pathologie-Biologie|May 1, 1992
[Emulsion of amphotericin B in Intralipid 20%: in vitro and in vivo efficacy]P Chavanet, N Charlier, A Brenet, et al.The Journal of Infectious Diseases|August 1, 1992
High concentrations of intrathecal interleukin-6 in human bacterial and nonbacterial meningitisP Chavanet, B Bonnotte, M Guiguet, et al.Lancet (London, England)|March 14, 1987
Acquired immunodeficiency syndrome after travelling in Africa: an epidemiological study in seventeen Caucasian patientsD Vittecoq, T May, R T Roue, et al.Journal of Virology|June 14, 2000
Epstein-Barr virus EB2 protein exports unspliced RNA via a Crm-1-independent pathwayG Farjot, M Buisson, M Duc Dodon, et al.Leukemia & Lymphoma|November 1, 1992
Bone marrow necrosis and human parvovirus associated infection preceding an Ph1+ acute lymphoblastic leukemiaT Petrella, F Bailly, F Mugneret, et al.Clinical and Vaccine Immunology : CVI|April 28, 2012
Performance of two commercially available automated immunoassays for the determination of Epstein-Barr virus serological statusJ Lupo, R Germi, T Semenova, et al.Vaccine|November 1, 1993
Three-week hepatitis B vaccination provides protective immunityB Marchou, N Picot, P Chavanet, et al.Journal of Virology|December 1, 1989
The Epstein-Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed under the control of EBV transcription factors EB1 and RM Buisson, E Manet, M C Trescol-Biemont, et al.Pageof 15